Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the early stages of type 2 diabetes
VALBIOTIS SA Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the e...
Source: businessinsider.com